A phase II study of plerixafor combined with whole brain radiation therapy (WBRT) for patients with newly diagnosed glioblastoma

被引：0
|
作者：
Cao, Toni
Gu, Yuan
Yagmurlu, Banu
Yerraballa, Hari Priya
Bertrand, Sophie
Naya, Lewis
Miller, Kate
Iv, Michael
Soltys, Scott G.
Patel, Chirag B.
Nagpal, Seema
Thomas, Reena Parada
Brown, Martin
Recht, Lawrence David
机构：
[1] Stanford Univ, Palo Alto, CA 94304 USA
[2] Stanford Canc Inst Palo Alto, Palo Alto, CA USA
[3] Stanford Canc Ctr GI Surg Oncol, Palo Alto, CA USA
[4] Stanford Canc Inst, Stanford, CA USA
[5] Stanford Univ, Stanford, CA 94305 USA
[6] Stanford Canc Ctr GI Surg Oncol, Stanford, CA USA
[7] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[8] Stanford Univ Hosp, Palo Alto, CA USA
[9] Stanford Univ Dept Psychiat & Behav Sci, Palo Alto, CA USA
[10] Stanford Univ Med Ctr, Palo Alto, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2075
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II study of hypofractionated radiation therapy in elderly patients with newly diagnosed glioblastoma with poor prognosis
    Navarria, Pierina
    Pessina, Federico
    Cozzi, Luca
    Tomatis, Stefano
    Reggiori, Giacomo
    Simonelli, Matteo
    Santoro, Armando
    Clerici, Elena
    Franzese, Ciro
    Carta, Giulio
    Nibali, Marco Conti
    Bello, Lorenzo
    Scorsetti, Marta
    TUMORI JOURNAL, 2019, 105 (01): : 47 - 54
  • [2] A PHASE II TRIAL OF PEMETREXED IN COMBINATION WITH WHOLE BRAIN RADIATION THERAPY (WBRT)
    Grilley-Olson, Juneko
    Morris, David
    Choksi, Janak K.
    Socinski, Mark A.
    Stinchcombe, Thomas
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1586 - S1586
  • [3] Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme
    Chang, SM
    Lamborn, KR
    Malec, M
    Larson, D
    Wara, W
    Sneed, P
    Rabbitt, J
    Page, M
    Nicholas, MK
    Prados, MD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (02): : 353 - 357
  • [4] Phase II trial of SurVaxM combined with standard therapy in patients with newly diagnosed glioblastoma.
    Ahluwalia, Manmeet Singh
    Reardon, David A.
    Abad, Ajay P.
    Curry, William T.
    Wong, Eric T.
    Belal, Ahmed
    Qiu, Jingxin
    Mogensen, Kathleen
    Schilero, Cathy
    Casucci, Danielle
    Mechtler, Laszlo
    Uhlmann, Erik J.
    Ciesielski, Michael J.
    Fenstermaker, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] PHASE II STUDY OF AZELIRAGON IN COMBINATION WITH RADIATION THERAPY IN NEWLY DIAGNOSED PATIENTS WITH MGMT-UNMETHYLATED GLIOBLASTOMA
    Huang, Jiayi
    Ahluwalia, Manmeet
    Boockvar, John
    Batiste, James
    Jaboin, Jerry
    Thotala, Dinesh
    Halasz, Lia
    Rammohan, Nikhil
    Ney, Douglas
    Malani, Rachna
    Chinnaiyan, Prakash
    Kotecha, Rupesh R.
    Mehta, Minesh
    Marcus, Stephen
    NEURO-ONCOLOGY, 2024, 26
  • [6] Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma
    Douglas E. Ney
    Julie A. Carlson
    Denise M. Damek
    Laurie E. Gaspar
    Brian D. Kavanagh
    B. K. Kleinschmidt-DeMasters
    Allen E. Waziri
    Kevin O. Lillehei
    Krishna Reddy
    Changhu Chen
    Journal of Neuro-Oncology, 2015, 122 : 135 - 143
  • [7] Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma
    Ney, Douglas E.
    Carlson, Julie A.
    Damek, Denise M.
    Gaspar, Laurie E.
    Kavanagh, Brian D.
    Kleinschmidt-DeMasters, B. K.
    Waziri, Allen E.
    Lillehei, Kevin O.
    Reddy, Krishna
    Chen, Changhu
    JOURNAL OF NEURO-ONCOLOGY, 2015, 122 (01) : 135 - 143
  • [8] OPEN-LABEL, RANDOMIZED PHASE II, OF CONCURRENT WHOLE BRAIN RADIATION THERAPY (WBRT) AND CAPECITABINE (XELODA®) FOLLOWED BY MAINTENANCE CAPECITABINE COMPARED WITH STANDARD WBRT IN BREAST CANCER PATIENTS WITH NEWLY DIAGNOSED BRAIN METASTASIS: THE XERAD TRIAL
    Carpentier, A.
    Peignaux, K.
    Bourgeois, H.
    Fauchon, F.
    Prevost, J.
    Azria, D.
    Toulemonde, A.
    Lortholary, A.
    Bonneterre, J.
    Hennequin, C.
    NEURO-ONCOLOGY, 2012, 14 : 78 - 79
  • [9] Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
    Lai, Albert
    Tran, Anh
    Nghiemphu, Phioanh L.
    Pope, Whitney B.
    Solis, Orestes E.
    Selch, Michael
    Filka, Emese
    Yong, William H.
    Mischel, Paul S.
    Liau, Linda M.
    Phuphanich, Surasak
    Black, Keith
    Peak, Scott
    Green, Richard M.
    Spier, Cynthia E.
    Kolevska, Tatjana
    Polikoff, Jonathan
    Fehrenbacher, Louis
    Elashoff, Robert
    Cloughesy, Timothy
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (02) : 142 - 148
  • [10] Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
    Kortmann, Rolf-Dieter
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (10) : 670 - 671
12345